Gene · 574456
Papers2,403
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,403
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Insights Into circRNA-Mediated Lipid Metabolism in Cancer Progression. | J Cell Mol Med | 2026 | 41652992 | PubTator, text mining | PubMed |
| Epigenetic dysregulation of B‑cells in autoimmune diseases and lymphomas (Review). | Int J Mol Med | 2026 | 41574706 | PubTator, text mining | PubMed |
| Evaluation of the Role of miRNAs Expression Profiles in Aneurysm. | Turk Neurosurg | 2026 | 41553216 | PubTator, text mining | PubMed |
| Construction of a novel prediction model based on albumin-hemoglobin score and serum microRNA-497-5p for prognosis of patients with stage II-III colorectal cancer. | Oncol Lett | 2026 | 41473699 | PubTator, text mining | PubMed |
| RETRACTION: Long Noncoding RNA CASC9 Promotes Pancreatic Cancer Progression by Acting as a ceRNA of miR-497-5p to Upregulate Expression of CCND1. | Environ Toxicol | 2026 | 41221704 | PubTator, text mining | PubMed |
| Extracellular vesicles for macrophage reprogramming: an emerging paradigm in immunomodulatory therapeutics. | J Biol Eng | 2025 | 41430279 | PubTator, text mining | PubMed |
| The Emerging Role of FAM171A2 in Gynecological Malignancies: Bioinformatic Insights from UCEC and Ovarian Cancer. | Int J Mol Sci | 2025 | 41303609 | PubTator, text mining | PubMed |
| Exosomal microRNA Panels for Detecting Early-Stage Non-Small Cell Lung Cancer. | Diagnostics (Basel) | 2025 | 41226027 | PubTator, text mining | PubMed |
| Retraction notice to "LncRNA GACAT3 promotes gastric cancer progression by negatively regulating miR-497 expression" [Biomed. Pharmacother. 97 (2018) 136-142]. | Biomed Pharmacother | 2025 | 41173698 | PubTator, text mining | PubMed |
| Integrated bioinformatics analysis identifies RPS27A and PPP2R1A as shared hub genes in heart failure and COVID-19. | J Cardiothorac Surg | 2025 | 41153026 | PubTator, text mining | PubMed |
| Bio fluid exosomes: promises, challenges, and future directions in translational medicine. | J Transl Med | 2025 | 40988065 | PubTator, text mining | PubMed |
| NUCKS1, a gene targeted by miR-497-5p, suppresses the antitumor effect of Brusatol and enhances malignancy of HNSCC via upregulating S100A9 expression. | Biochem Pharmacol | 2025 | 40946978 | PubTator, text mining | PubMed |
| Bibliometric analysis of research on cervical cancer and miRNAs from 2010 to 2024: research trends, hotspots, and prospects. | Discov Oncol | 2025 | 40864203 | PubTator, text mining | PubMed |
| The Role of Non-Coding RNAs in the Regulation of Oncogenic Pathways in Breast and Gynaecological Cancers. | Noncoding RNA | 2025 | 40863727 | PubTator, text mining | PubMed |
| The assessment of breast cancer biomarkers in diagnosis, prognosis and treatment monitoring: integrated analysis. | J Cancer Res Clin Oncol | 2025 | 40844552 | PubTator, text mining | PubMed |
| Opposing mechanisms by which miRNAs mediate distinct Nrf1 and Nrf2 regulation of epithelial-mesenchymal transition in hepatocellular carcinoma. | RNA Biol | 2025 | 40836845 | PubTator, text mining | PubMed |
| Retraction: MicroRNA-497 suppresses renal cell carcinoma by targeting VEGFR-2 in ACHN cells. | Biosci Rep | 2025 | 40824216 | PubTator, text mining | PubMed |
| Targeting LINC02544/miR-497-5p/CAPRIN1 axis via exosome-based siRNA to overcome immunotherapy resistance in triple-negative breast cancer. | Mol Med | 2025 | 40819077 | PubTator, text mining | PubMed |
| Cancer stem cells in personalized therapy: mechanisms, microenvironment crosstalk, and therapeutic vulnerabilities. | Front Cell Dev Biol | 2025 | 40809695 | PubTator, text mining | PubMed |
| MicroRNA Expression Analysis and Biological Pathways in Chemoresistant Non-Small Cell Lung Cancer. | Cancers (Basel) | 2025 | 40805201 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/574456/papers?page=2